Skip to content

Embecta Corp. EMBC Contract Manufacturing — Revenue

Other product segments

Pen Needles
$154.7M-17.8%
Safety
$34.3M+0.3%
Syringes
$26.3M-8.7%

Similar metrics at other companies

Elanco Animal Health Inc. logo
ELANContract Manufacturing — Revenue
$19M+58.3%
Biogen logo
BIIBContract manufacturing revenue — Total Revenue
$237.2M-16.0%
Rocky Brands logo
RCKYContract Manufacturing — Revenue (Gross)
$3.31M+25.0%
Alkermes logo
ALKSManufacturing Revenue — Revenue
$4.07M-76.5%
Veracyte logo
VCYTContract manufacturing and testing — Total Revenue
$0-100%
Sarepta Therapeutics, Inc. logo
SRPTContract Manufacturing Revenue — Revenue From Collaborative Arrangement Excluding Revenue From Contract With Customer
$31.11M+79.0%

Other financials

Income statement

See full
Revenue$221.8M-14.4%
Gross profit$127.8M-22.1%
Operating income$35.0M-44.4%
Net income-$4.1M-117%
EPS (diluted)-$0.07-118%

Balance sheet

See full
Cash & equivalents$193.4M-8.9%
Total debt$1.4B-12.5%
Total equity-$626.1M+15.0%
Total assets$1.0B-8.1%

Cash flow

See full
Operating cash flow$31.1M-2.2%
CapEx$500.0K+400%
Free cash flow$30.6M-3.5%

Valuation

See full
Market cap$193.41M-64.3%
Enterprise value$1.37B-24.8%
P/E1.7×-4.8×
P/S0.2×-0.3×

Profitability

See full
Gross margin61.9%-1.6pp
Operating margin25.8%+9.7pp
Net margin10.7%+5.8pp
FCF margin19.6%+16.0pp

Returns & leverage

See full
Return on equity71.9%
Debt / equity
Current ratio2.5×0.0×

Where this comes from

Reported directly by Embecta Corp. in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The official record: Embecta Corp.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Embecta Corp.'s contract manufacturing — revenue.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Embecta Corp.'s contract manufacturing — revenue?
Embecta Corp. (EMBC) reported contract manufacturing — revenue of $2.5M in Q1 2026.
How has Embecta Corp.'s contract manufacturing — revenue changed year-over-year?
Embecta Corp.'s contract manufacturing — revenue decreased by 43.2% year-over-year, from $4.4M to $2.5M.
What is the long-term trend for Embecta Corp.'s contract manufacturing — revenue?
Over 3 years (2022 to 2025), Embecta Corp.'s contract manufacturing — revenue has grown at a 9.9% compound annual growth rate (CAGR), from $15M to $19.9M.
What does contract manufacturing — revenue mean?
This metric represents the total gross revenue generated from providing manufacturing services to third-party clients for medical devices or related components. It reflects the company's ability to leverage its existing production infrastructure and technical expertise to generate non-core income streams. Monitoring this figure helps investors assess the scale and growth trajectory of the company's outsourced manufacturing operations relative to its primary product portfolio.